Hiroomi Tada - Jul 28, 2023 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Medical Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Jul 28, 2023
Transactions value $
$0
Form type
4
Date filed
8/1/2023, 05:41 PM
Previous filing
Mar 17, 2023
Next filing
Sep 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Award $0 +115K $0.00 115K Jul 28, 2023 Common Stock 115K $14.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.